Sambrosa: Nature's Nighttime Remedy Arrives in America

Invest in the U.S. company owned by the same team who created this popular nighttime syrup that has more than 100,000 customers in Europe.

  • America has more than 50,000,000 people who suffer from sleep problems.
  • Sleep aid market in U.S. was valued at more than $29 billion in 2022 and is projected to reach $54 billion by 2032.
  • Our sister company's EU nighttime syrup with the same formula has an average 9/10 star rating based on more than 13,500 online reviews. Since opening in America, our U.S. product already has an average 4.7 star rating based on more than 750 reviews
INVEST NOWArrow-right
Sambrosa Care healthcare

Sambrosa Care Inc.

Company name

$1,000,000

Offering amount

$5.00

Price per share

$250

Minimum investment

Bringing Success To The U.S.

Sambrosa Care Inc. is our U.S. based company and is accepting investments to grow Sambrosa Care in the United States. We're excited to give you the opportunity to invest in Sambrosa's U.S. operations at this early stage, and to own a part of every bottle of Sambrosa Sweet Dreams Night Syrup we sell here in the largest market in the world.

About image one
About image one

Great Taste and FDA Registered

Sambrosa Sweet Dreams Night Syrup is made with high-quality ingredients such as honey, 7 organic herbs, and a small dose of doxylamine, so it's not only effective, but it also tastes great.

It's produced by a specialized pharmaceutical manufacturing company that's registered with the FDA and has Current Good Manufacturing Practice certification to ensure the highest possible standard in quality.

Our Story

It worked so well, we bought the company!

Sambrosa began with a remarkable discovery. When founder John Van Hierden came across Sambrosa in the European market, he was immediately impressed by its quality and effectiveness in supporting restful sleep and overall wellness.

Recognizing its potential to improve lives, John decided to acquire the Sambrosa formula and the company itself. With a strong background in entrepreneurship as the founder and President of the Green Prairie Group (an integrated company that has generated $100M in revenues per year for the past two years), he brought both experience and passion to guiding Sambrosa's growth.

Today, Sambrosa remains a family-owned business, driven by a shared belief in integrity, quality, and care. Together, we're proud to carry forward a mission that began with one simple idea—helping people get the rest and wellness they deserve.

Story image one
Story image two

Our Customers Love Us!

Average Review: 4.7 of 5 Stars in the U.S.

What do people who have used Sambrosa say? We have an average 4.7-star rating based on more than 750 online reviews from the U.S. company you can invest in. It's the same formula that our sister company in Europe uses for their product, which has an average 9/10-star rating based on over 13,500 online reviews.

Note that you are not investing in our sister company, but in our U.S. company that is presently rolling out our highly reviewed nighttime syrup across America.

Quality Ingredients = Quality Sleep

Why does Sambrosa Sweet Dreams work so well, but also taste so great?

Quality ingredients.

Each spoonful contains a low dose of the antihistamine doxylamine succinate—the active ingredients that helps minimize allergy symptoms so you can have your best night's rest.

What we believe sets Sambrosa apart from any other product on the market is its natural base of seven organic herbs — including California poppy, hawthorn, hops, mistletoe, oat, passion flower and white chestnut.

We use honey as a natural sweetener, not high-fructose corn syrup like many other syrups on the market.

Add a touch of vanilla, and put it all together with no dyes, artificial coloring, or flavors, and you have an over-the counter nighttime syrup that is so effective, we consistently get high online reviews and a large percentage of loyal repeat customers.

Ingredients image

Want To Be A Part Of
Our Growing U.S. Company?

CTACard image

Investor Perks

For an investment of $250.00, 50 shares of real stock in our company.

For an investment of $255.00-$500.00, shares of real stock in our company at $5.00 per share and

  • 10% off all purchases you make for one year after being issued your shares (limited to one purchase per month) and
  • We will send a free sample of Sambrosa to two people you select, as a gift from you, so they can also experience nighttime relief from the product you own a part of!

For an investment of $505.00 or more, shares of real stock in our company at $5.00 per share and

  • 10% off all purchases you make for two years after being issued your shares (limited to one purchase per month) and
  • We will send a free sample of Sambrosa to five people you select, as a gift from you, so they can also experience nighttime relief from the product you own a part of!
Story image one

Downloads

Access important documents and resources related to your investment opportunity

Form C - Offering Statement

The official SEC Form C filing containing the complete offering details and disclosure information.

Subscription Agreement

The subscription agreement outlining the terms and conditions for your investment.

TomboyX Logo

COPYRIGHT © 2026 Cultivate Capital Group, LLC. All Rights Reserved.

www.CultivateCapitalcf.org is a website owned and operated by Cultivate Capital Group, LLC ("Cultivate Capital"). All Regulation Crowdfunding activities on www.CultivateCapitalcf.org are conducted by Cultivate Capital, a broker-dealer registered with the U.S. Securities and Exchange Commission and a member of the Financial Industry Regulatory Authority (FINRA).

All securities listed on www.CultivateCapitalcf.org are being offered by the applicable issuer of such securities and all information included on this website related to those securities is the responsibility of each such issuer. The information on our website regarding any issuer or in a blog post is based on publicly available information or directly from the subject issuer. Cultivate Capital and its affiliates make no representation or warranty as to the adequacy, accuracy or completeness of such information. Any written materials on our website have been prepared solely for informative purposes and are not a solicitation of an offer to buy or an offer to sell any security. Cultivate Capital does not give investment advice, recommendations, or analysis as to any securities through www.CultivateCapitalcf.org or in any other manner, nor does it endorse or recommend investments in any company or the suitability of an investment for any particular investor. Cultivate Capital does not provide any legal or tax advice with respect to any securities. Neither Cultivate Capital nor any of its officers, directors, agents, registered representatives and/or employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information submitted by or presented. No securities offered on this website have been recommended or approved by any federal or state securities commission or regulatory authority, including but not limited to, the U.S. Securities and Exchange Commission.

By using www.CultivateCapitalcf.org, you accept and agree to be bound by the site's Terms of Use and Privacy Policy as may be amended from time to time without notice or liability. Please be aware that Cultivate Capital or its affiliates receive fees from issuers posted on our website at www.CultivateCapitalcf.org. Details about our compensation are disclosed in the offering materials for each issuer conducting a live offering. Cultivate Capital may choose to compensate outside sources to help market our business and to receive introductions to possible issuers. Compensation to such parties will not be based on the success or size of any transaction and fees will not be based directly or indirectly on the purchase or sale of any security. Blog posts or the posting of information on our website regarding any issuer, including any links to information either in the blog post or on our website, should not be construed as an endorsement or recommendation of that issuer for any purpose whatsoever. Links are provided for information only and Cultivate Capital and its affiliates are not responsible for any information at the sites linked to. Blog posts or the posting of information on our website does not take into account the investment objectives, financial situation or needs of any particular investor, and each investor should consider whether any investment opportunity is appropriate given their investment objectives and current financial circumstances. Any person considering any investment is encouraged to consult with their own investment or financial advisor, tax advisor and/or attorney before making any investment.

All investments entail risk. The issuers on our site are generally small or early-stage companies and are subject to risks inherent in investing in any small or early-stage company as well as other risks specific to their business and operations. In addition, securities of these issuers may be highly illiquid, requiring that they be held for an indefinite period of time or have a limited market for resale. Therefore, no one should invest in any of these issuers unless they have no need for liquidity of their investment and can sustain a total loss of their investment. You should only invest an amount of money that you can afford to lose without changing your lifestyle. You should thoroughly review the complete offering materials for any investment opportunity, particularly all risk factors, prior to investing in any offering and become familiar with the investor requirements, investment limits and your ability to resell the investment.

The information on this website relating to Sambrosa Care, Inc. ("Sambrosa") was provided by Sambrosa to assist with marketing their Regulation Crowdfunding stock offering. The text on any webpages related to Sambrosa is a summary but does not contain all of the terms of their securities offering. In order to review all of the terms of their securities offering, you should review their Form C and Offering Statement that contains all of the terms, conditions, risk factors, and disclosures that you should read and understand before you invest in their company. Their Form C and Offering Statement is available to download here for you to read and review before you invest. You can also view it on the SEC's website here.

The Form C and Offering Statement explains that Sambrosa is offering 200,000 Shares of Preferred Non-Voting stock at $5.00 per share with a minimum purchase of 50 Shares ($250.00). The U.S. Securities and Exchange Commission (SEC) does not pass upon the merits of, or give its approval to, any of the securities that are being offered or the terms of the offering, nor does it pass upon the accuracy or completeness of the Form C and Offering Statement, other selling literature or this website. The securities Sambrosa are offering are offered pursuant to an exemption from registration with the SEC; however, the SEC has not made an independent determination that the securities offered in their Form C and Offering Statement and in their offering are exempt from registration. When you review their Form C and Offering Statement, please review all of the risk factors before making an investment in their company. An investment in Sambrosa should only be made if you are capable of evaluating the risks and merits of this investment and if you have sufficient resources to bear the entire loss of your investment, should that occur.

If you are an accredited investor, you have no limitation on the amount you may invest. If you are not an accredited investor, then the amount you may invest is limited by Regulation Crowdfunding. These limitations provide that if either your income or net worth is less than $124,000, you can invest the greater of $2,500 or 5% of your higher income or net worth figure. If either your income or net worth is $124,000 greater, you may invest up to 10% of the larger value. Regardless of income or net worth, all non-accredited investors are subject to a $124,000 ceiling on total Regulation Crowdfunding investments within a 12-month span.

For general information on investing, we encourage you to review www.investor.gov. Sambrosa's Form C and Offering Statement does not constitute an offer or solicitation in any jurisdiction in which such an offer or solicitation would be unlawful. No person has been authorized to give any information or to make any representations concerning Sambrosa other than those contained in their Form C and Offering Statement, and if given or made, such other information or representation must not be relied upon. Prospective investors are not to construe the contents of Sambrosa's Form C and Offering Statement, or of any prior or subsequent communications from Sambrosa or any of its employees, agents or affiliates, or on this website as investment, legal, financial or tax advice. Before investing in Sambrosa's offering, please review their Form C and Offering Statement carefully, ask any questions of the company's management that you would like answered and consult your own counsel, accountant and other professional advisors as to legal, tax and other related matters concerning the investment.

551-279-3744


CULTIVATE CAPITAL GROUP LLC IS A MEMBER OF FINRA.


CRD#: 300634 SEC#: 8-70293


RESOURCES: